» Articles » PMID: 20101623

Improving Adeno-associated Vector Yield in High Density Insect Cell Cultures

Overview
Journal J Gene Med
Date 2010 Jan 27
PMID 20101623
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recombinant adeno-associated virus (rAAV) are the most promising vectors for gene therapy. However, large-scale rAAV production remains a challenge for the translation of rAAV-based therapeutic strategies to the clinic. The baculovirus expression vector system (BEVS) has been engineered to produce high rAAV titers in serum-free suspension cultures of insect cells.

Methods: The typical approach of rAAV production in BEVS has been based on a synchronous infection with three baculoviruses at high multiplicity of infection (MOI) [>3 plaque forming units (pfu)/cell]. An alternative approach is to co-infect at low MOI (0.1 pfu/cell). Both strategies (high and low MOI) were compared at a cell density of 1.0 x 10(6) cells/ml in shake-flask experiments. To increase the rAAV titer, a low MOI combined with an initial cell density at infection of 5.0 x 10(6) cells/ml, in fed-batch mode, was evaluated. Subsequently, the production strategy was validated in 3-l bioreactor runs.

Results: An increase of 210% in the rAAV titer (4.7 x 10(11) enhanced transduction units/l) was observed when using low MOI, an effect primarily caused by the increase in cell density. The fed-batch approach resulted in a seven-fold increase of rAAV yield. Controlled operations in bioreactor contributed to further increase the rAAV yield (2.8 x 10(14) vector genomes/l) by 25% in comparison to the shake flask results.

Conclusions: This high yield production process using low MOIs and a feeding strategy successfully addresses several limitations of current rAAV production in insect cells and contributes to position the BEVS system as one of the most efficient for large-scale manufacturing of rAAV vectors.

Citing Articles

An automated and high-throughput approach for enhanced precision of adenoviral titering.

Bottega P, Fusciello M, Hamdan F, Chiaro J, Russo S, DAlessio F Mol Ther Methods Clin Dev. 2025; 33(1):101410.

PMID: 39968184 PMC: 11834061. DOI: 10.1016/j.omtm.2025.101410.


Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture.

Li X, Gu J, Wu H, Xie Y Virol J. 2024; 21(1):281.

PMID: 39511576 PMC: 11542467. DOI: 10.1186/s12985-024-02550-4.


Recombinant AAV Production.

Joshi P, Venereo-Sanchez A Methods Mol Biol. 2024; 2829:203-214.

PMID: 38951336 DOI: 10.1007/978-1-0716-3961-0_14.


Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.

Destro F, Joseph J, Srinivasan P, Kanter J, Neufeld C, Wolfrum J Mol Ther Methods Clin Dev. 2023; 30:122-146.

PMID: 37746245 PMC: 10512016. DOI: 10.1016/j.omtm.2023.05.019.


Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method.

Rao R, Farraha M, Logan G, Igoor S, Kok C, Chong J Viruses. 2022; 14(8).

PMID: 35893689 PMC: 9341392. DOI: 10.3390/v14081623.